Vitro, S.A.B. de C.V.
VITOF
$0.66
-$0.01-1.49%
OTC PK
| 09/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | 72.11M | 71.00M | 79.16M | 80.97M | 81.00M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 72.11M | 71.00M | 79.16M | 80.97M | 81.00M |
| Cost of Revenue | 42.16M | 38.00M | 40.69M | 40.94M | 41.00M |
| Gross Profit | 29.95M | 33.00M | 38.47M | 40.03M | 40.00M |
| SG&A Expenses | 24.99M | 26.00M | 28.49M | 29.94M | 30.00M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -1.16M | -- | -7.73M | 3.23M | 3.00M |
| Total Operating Expenses | 65.99M | 64.00M | 61.46M | 74.11M | 74.00M |
| Operating Income | 6.12M | 7.00M | 17.70M | 6.86M | 7.00M |
| Income Before Tax | -36.03M | 25.00M | 28.58M | -2.68M | -3.00M |
| Income Tax Expenses | -1.57M | -1.00M | 9.71M | -887.00K | -1.00M |
| Earnings from Continuing Operations | -34.46M | 26.00M | 18.86M | -1.80M | -2.00M |
| Earnings from Discontinued Operations | -- | -- | 69.44M | 16.10M | 16.00M |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | 43.00K | 44.00K | -- |
| Net Income | -34.46M | 26.00M | 88.34M | 14.35M | 14.00M |
| EBIT | 6.12M | 7.00M | 17.70M | 6.86M | 7.00M |
| EBITDA | 9.93M | 10.59M | 56.87M | 46.03M | 46.17M |
| EPS Basic | -0.07 | 0.06 | 0.20 | 0.03 | 0.03 |
| Normalized Basic EPS | -0.05 | -- | 0.04 | 0.00 | -- |
| EPS Diluted | -0.07 | 0.06 | 0.20 | 0.03 | 0.03 |
| Normalized Diluted EPS | -0.05 | -- | 0.04 | 0.00 | -- |
| Average Basic Shares Outstanding | 492.26M | 470.03M | 437.19M | 478.33M | 470.03M |
| Average Diluted Shares Outstanding | 492.26M | 470.03M | 437.19M | 478.33M | 470.03M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |